Why US biotech Axiom is starting its IPO journey in Hong Kong
Why US biotech Axiom is starting its IPO journey in Hong Kong.
Axiom
Private
AI Toxicity Modeling
Company Info
Recent News
Axiom plans Hong Kong IPO, hoping to carve new path for US biotechs
Axiom plans Hong Kong IPO, hoping to carve new path for US biotechs.
Axiom hopes it ‘solved 2 major potholes’ for stem cell biotechs
Axiom hopes it ‘solved 2 major potholes’ for stem cell biotechs
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer
Careers & Job Openings